OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Merck & Co Inc/  US58933Y1055  /

Cboe Europe CXE
2024-07-31  12:45:07 PM Chg. - Volume Bid5:27:43 PM Ask5:27:45 PM Market Capitalization Dividend Y. P/E Ratio
108.00EUR - 80
Turnover: 8,640		 106.20Bid Size: 160 106.80Ask Size: 160 271.19 bill.EUR - -
TeleTrader 07-30 Merck falls 7% after Q2 earnings report
TeleTrader 07-30 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 07-17 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
GlobeNewswire 07-09 Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination ...
GlobeNewswire 06-27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 06-25 Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of...
GlobeNewswire 06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 06-06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 06-05 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 06-03 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
TeleTrader 05-29 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 05-29 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 05-29 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-06 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 05-02 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-06 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 03-04 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 02-02 Merck Group to expand investment in South Korea
TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B
TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 01-23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...